Search Results - "Haubrich, R."

Highly flexible, wearable, and disposable cardiac biosensors for remote and ambulatory monitoring by Lee, Stephen P., Ha, Grace, Wright, Don E., Ma, Yinji, Sen-Gupta, Ellora, Haubrich, Natalie R., Branche, Paul C., Li, Weihua, Huppert, Gilbert L., Johnson, Matthew, Mutlu, Hakan B., Li, Kan, Sheth, Nirav, Wright, John A., Huang, Yonggang, Mansour, Moussa, Rogers, John A., Ghaffari, Roozbeh

“…Contemporary cardiac and heart rate monitoring devices capture physiological signals using optical and electrode-based sensors. However, these devices…”
Get full text

Digitizing Medicines for Remote Capture of Oral Medication Adherence Using Co‐encapsulation by Browne, SH, Peloquin, C, Santillo, F, Haubrich, R, Muttera, L, Moser, K, Savage, GM, Benson, CA, Blaschke, TF

“…High‐resolution measurement of medication adherence is essential to personalized drug therapy. A US Food and Drug Administration (FDA)‐cleared device, using an…”
Get full text

Pooling Strategies to Reduce the Cost of HIV-1 RNA Load Monitoring in a Resource-Limited Setting by van Zyl, G.U., Preiser, W., Potschka, S., Lundershausen, A.T., Haubrich, R., Smith, D.

“…Background. Quantitative human immunodeficiency virus (HIV) RNA load testing surpasses CD4 cell count and clinical monitoring in detecting antiretroviral…”
Get full text

The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women by Morales, A. J., Haubrich, R. H, Hwang, J. Y., Asakura, H, Yen, S. S. C

“…OBJECTIVE The biological role of the adrenal sex steroid precursors ‐ DHEA and DHEA sulphate (DS) and their decline with ageing remains undefined. We observed…”
Get full text

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response by HAUBRICH, R. H, LITTLE, S. J, CURRIER, J. S, FORTHAL, D. N, KEMPER, C. A, BEALL, G. N, JOHNSON, D, DUBE, M. P, HWANG, J. Y, MCCUTCHAN, J. A

“…Objective: To correlate self-reported antiretroviral adherence with virologic suppression. Design: Prospective observational study of adherence to therapy…”
Get full text

Efficacy and safety of ledipasvir/sofosbuvir, with or without ribavirin, for treatment of hepatitis C virus-mono and HCV/HIV co-infected patients who have failed prior treatment with non-NS5A, SOF-based therapies by Tam, E, Brown, R.S, Satapathy, S, Shen, X, Camus, G, Copans, A, Rossaro, L, Guyer, W, Haubrich, R, Kiser, J, Kang, M, Umbleja, T, Luetkemeyer, A

Get full text

Differential escape patterns within the dominant HLA-B57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints by Payne, R P, Branch, S, Kløverpris, H, Matthews, P C, Koofhethile, C K, Strong, T, Adland, E, Leitman, E, Frater, J, Ndung'u, T, Hunter, E, Haubrich, R, Mothe, B, Edwards, A, Riddell, L, Chen, F, Harrigan, P R, Brumme, Z L, Mallal, S, John, M, Jooste, J P, Shapiro, R, Deeks, S G, Walker, B D, Brander, C, Landis, C, Carlson, J M, Prado, J G, Goulder, P J R

“…HLA-B*57:01 and HLA-B*57:03, the most prevalent HLA-B*57 subtypes in Caucasian and African populations, respectively, are the HLA alleles most protective…”
Get full text

Community HIV‐1 drug resistance is associated with transmitted drug resistance by Tilghman, MW, Pérez‐Santiago, J, Osorio, G, Little, SJ, Richman, DD, Mathews, WC, Haubrich, RH, Smith, DM

“…Objectives As community viral load (CVL) measurements are associated with the incidence of new HIV‐1 infections in a population, we hypothesized that similarly…”
Get full text

Ion PGM deep sequencing improves mutation detection in infants who failed PMTCT by Fisher, R.G, Pond, S. Kosakovsky, Murrel, B, Slabbert, R, Edson, C, Cotton, M.F, Haubrich, R, Smith, D, van Zyl, G

Get full text

Clinical Utility of Resistance Testing: Retrospective and Prospective Data Supporting Use and Current Recommendations by Haubrich, Richard, Demeter, Lisa

Get full text

Phenotypic and Genotypic Resistance Assays: Methodology, Reliability, and Interpretations by Demeter, Lisa, Haubrich, Richard

Get full text

Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing by Witt, Mallory D., Lewis, Roger J., Larsen, Robert A., Milefchik, Eric N., Leal, Mary Ann E., Haubrich, Richard H., Richie, John A., Edwards, John E., Ghannoum, Mahmoud A.

“…No method currently exists to predict which patients with acute AIDS-associated cryptococcal meningitis can be effectively treated with fluconazole. The…”
Get full text

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter by Hammer, Scott M, Katzenstein, David A, Hughes, Michael D, Gundacker, Holly, Schooley, Robert T, Haubrich, Richard H, Henry, W. Keith, Lederman, Michael M, Phair, John P, Niu, Manette, Hirsch, Martin S, Merigan, Thomas C

“…Zidovudine improves survival and decreases the incidence of opportunistic infections among patients with advanced infections with human immunodeficiency virus…”
Get full text

International perspectives on antiretroviral resistance. Clinical utility of resistance testing: retrospective and prospective data supporting use and current recommendations by Haubrich, R, Demeter, L

“…Data from retrospective and prospective studies support use of genotypic and phenotypic resistance assays to guide treatment changes when initial or subsequent…”
Get full text

International perspectives on antiretroviral resistance. Phenotypic and genotypic resistance assays: methodology, reliability, and interpretations by Demeter, L, Haubrich, R

“…Phenotypic and genotypic resistance assays-methods to measure the susceptibility of HIV to drug therapy-are becoming widely available to clinicians for use in…”
Get full text

High-Dose Fluconazole for Treatment of Cryptococcal Disease in Patients with Human Immunodeficiency Virus Infection by Haubrich, Richard H., Haghighat, Dennis, Bozzette, Samuel A., Tilles, Jeremiah, McCutchan, J. Allen

“…Eight patients (6, cryptococcal meningitis; 2, high-titer cryptococcal antigenemia) were treated with 800 mg/day fluconazole to assess the safety and efficacy…”
Get full text

The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis by HAUBRICH, Richard H, KEMPER, Carol A, MCCUTCHAN, J. Allen, HELLMANN, Nicholas S, KEISER, Philip H, WITT, Mallory D, FORTHAL, Donald N, LEEDOM, John, LEIBOWITZ, Matthew, WHITCOMB, Jeannette M, RICHMAN, Douglas

“…To evaluate the clinical significance of hypersusceptibility to non-nucleoside reverse transcriptase inhibitors (NNRTI). Analysis of a prospective clinical…”
Get full text

POSB13 Thirty-Day Readmission in US Hospitalized COVID-19 Patients by Mozaffari, E, Liang, S, Stewart, HM, Thrun, M, Hodgkins, P, Haubrich, R

Get full text

Disseminated Mycobacterium avium Complex: Correlation between Blood and Tissue Burden by Torriani, Francesca J., Behling, Cynthia A., McCutchan, J. Allen, Haubrich, Richard H., Havlir, Diane V.

“…To determine the relationship between levels of Mycobacterium avium complex (MAC) in blood and tissues, histopathologic examination and quantitative MAC…”
Get full text

A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy : CCTG 575 by HAUBRICH, Richard H, KEMPER, Carol A, RICHMAN, Douglas D, HELLMANN, Nicholas S, KEISER, Philip H, WITT, Mallory D, TILLES, Jeremiah G, FORTHAL, Donald N, LEEDOM, John, LEIBOWITZ, Matthew, MCCUTCHAN, J. Allen

“…To assess phenotype susceptibility testing (PHENO) with standard of care (SOC) to improve antiretroviral therapy. A prospective, multicenter study of 238…”
Get full text